Literature DB >> 33591065

Obesity as a Predictor of Outcomes in Type III & IV Supracondylar Humerus Fractures.

Alexander Nazareth1, Mathew Schur, Amanda J Schroeder, Patrick W Whitlock, David L Skaggs, Rachel Y Goldstein.   

Abstract

OBJECTIVES: To investigate the association of obesity with fracture characteristics and outcomes of operatively treated pediatric supracondylar humerus fractures.
DESIGN: Retrospective multicenter.
SETTING: Two Level I pediatric hospitals. PATIENTS: Patients (age < 18 years) with operatively treated Gartland type III and IV fractures 2010-2014. INTERVENTION: Closed or open reduction and percutaneous pinning of supracondylar humerus fractures. MAIN OUTCOME MEASUREMENT: Incidence of Gartland IV fracture, pre-operative nerve palsy, open reduction and complication rates.
RESULTS: Patients in the obese group had a significantly higher likelihood of having a Gartland IV fracture (NOT OBESE: 17%, OBESE: 35%, p =0.007). There was a significantly higher incidence of nerve palsy on presentation in the OBESE group (NOT OBESE: 20%, OBESE: 33%, p=0.03). No significant differences were found between groups regarding incidence of open reduction, compartment syndrome and rates of re-operation.
CONCLUSION: The present study demonstrates that obese children with a completely displaced supracondylar humerus fractures have an increased risk of Gartland type IV and pre-operative nerve palsy compared to normal weight children. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33591065     DOI: 10.1097/BOT.0000000000002081

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  1 in total

1.  Determining the stability of minimally displaced lateral humeral condyle fractures in children: ultrasound is better than arthrography.

Authors:  Andreas Rehm; Tamás Kobezda; Elizabeth Ashby
Journal:  J Orthop Surg Res       Date:  2021-11-30       Impact factor: 2.359

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.